Biocentric Energy Holdings, Inc. (BEHL)

[FTW]

Solazyme Revenues per AUDITED Financials:
2009: $9 million
2010: $38 million
2011 Q1: $8 million
IPO last week: ~$200 million.

Regardless of how they do, they have revenues from the gov't and other funding sources, and they have audited financials with real data.

BEHL has zero. Zero revenues, zero grants, zero funding sources, and never ever any chance of audited financials in order to uplist.


So in regards to your questions about budget, how do you think that income statement will look with an additional $200million in revenues from the IPO (since your data is from March 31st 2011)? Still negative? I think not.